| Quote | Spy EXEL NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Exelixis Posts Q4 EPS of $0.27, In-Line with Views; Guides FY10 Revs Above Street
EXEL Linked by StreetInsider - March 09, 06:49AM from (www.streetinsider.com) more ...
Exelixis Announces Fourth Quarter and Full Year 2009 Financial Results
EXEL Linked by BusinessWire - March 09, 06:15AM from (www.businesswire.com) Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the fourth quarter and year ended December 31, 2009. Revenues more ...
Exelixis Announces Restructuring
EXEL Linked by BusinessWire - March 08, 04:00PM from (www.businesswire.com) Exelixis, Inc. (Nasdaq:EXEL) today announced a restructuring as a consequence of its continued strategy to focus resources more ...
Exelixis Announces March 9 Webcast of Its Fourth Quarter and Full Year 2009 Financial Results Conference Call
EXEL Linked by BusinessWire - March 02, 06:30AM from (www.businesswire.com) Exelixis, Inc. (Nasdaq:EXEL) will release its fourth quarter and full year 2009 financial results on Tuesday, March 9, 2010 more ...
Healthcare a Focus for Big Moves by Icahn
FRX MOT GENZ BIIB AMLN LGF EXEL TTWO YHOO ARII Linked by tickerspy blog - February 19, 08:54AM from (www.tickerspy.com) Legendary investor Carl Icahn, known for making headlines with big moves in the market, was increasing a handful of his major stakes during Q4. more ...
Exelixis Announces Webcast of Its Fifth Annual R&D Day on December 2
EXEL Linked by BusinessWire - November 24, 08:30AM from (www.businesswire.com) Exelixis, Inc. (NASDAQ:EXEL) announced today that it will hold its Fifth Annual R&D Day on Wednesday, December 2, 2009 more ...
Icahn Makes Big Moves in Healthcare Stocks
FRX MOT GENZ MSFT BIIB AMLN LGF EXEL TTWO YHOO ARII Linked by tickerspy blog - November 23, 09:13AM from (www.tickerspy.com) Legendary investor Carl Icahn, known for making headlines with big moves in the market, opened a pair of major stakes in the healthcare sector during Q3. more ...
Four Healthcare Stocks On Fire
BMY EXEL ISRG NVS SNY WCG Linked by Investopedia Stock Analysis - November 18, 05:13PM from (stocks.investopedia.com) Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation for the more ...
Ligand Updates License Agreement with Exelixis
LGND EXEL Linked by BusinessWire - November 02, 08:30AM from (www.businesswire.com) Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has amended its license agreement with Exelixis, Inc. (NASDAQ: EXEL) as more ...
Exelixis Tops Q3 EPS by 8c; Comments on Outlook
BMY EXEL SNY Linked by StreetInsider - October 29, 05:03PM from (www.streetinsider.com) more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2010 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.
|
|